TrialThe Lancet. Respiratory medicine2022

Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.

John W Eikelboom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.